BioSpace News Archive

CellCarta, a global provider of precision medicine services, announced today the acquisition of Reveal Biosciences a San Diego California based computational pathology company offering cutting-edge artificial intelligence (AI)-based quantitative pathology and immunohistochemistry services to the biopharmaceutical industry.

Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, announced that its new COVID-19 Antigen Rapid Test can now be performed with a simple less invasive nasal swab

HiFiBiO Therapeutics Announces Publication in Nature Communications on its SARS-CoV-2 Neutralizing Monoclonal Antibody HFB30132A possesses differentiated properties providing strong potential for COVID-19 treatment and prevention

Encouraging data support single-agent efficacy across key measures including complete remission (CR) with negative minimal residual disease (MRD) rates, duration of response and overall survival in front-line therapy of AML patients unfit for intensive chemotherapy

Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, today announced it has acquired global rights to ASP3652, a novel oral peripherally restricted fatty acid amide hydrolase (FAAH) inhibitor from Astellas Pharma Inc.

HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced the completion of patient enrollment in the Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms and Revascularization (PRECISE) randomized controlled trial. Physicians from more than 50 hospitals around the world successfully enrolled 2,100 patients.

Mawi DNA Technologies, a biotechnology company focusing on the development of innovative technologies for biosampling, announces that MagBio Genomics has successfully developed an automated RNA purification method for iSWAB-RNA v2 on the Thermofisher KingFisher™ Flex platform with its HighPrep™ Total RNA Isolation Kit - iSWAB™.

BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, today announced a Master Clinical Research Collaboration Agreement with the Abramson Cancer Center (ACC) of the University of Pennsylvania to support multiple research projects at the cancer center.

Ms. Gorski brings more than two decades of communications and patient advocacy experience serving rare disease communities Formerly led global communications and patient advocacy strategies for lysosomal storage disorders at Sanofi Genzyme

Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction -based DNA manufacturing, announced that its Applied DNA Clinical Labs, LLC subsidiary received CLIA certification from the New York State Department of Health Clinical Laboratory Evaluation Program for COVID-19 testing using EUA-authorized methods and devices.